Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Factors Contributing to Palliative Care Use in Pancreatic Cancer: A Review of the 2004 - 2016 National Cancer Database

Gabriela L. Aitken, Patrick T. Reynolds, Christopher J. Gannon, Omar H. Llaguna

Introduction: Palliative Care (PC) is offered to patients with pancreatic cancer with the aim of providing symptomatic relief and enhancing quality of life. Despite its benefits, utilization varies. The purpose of this study was to determine factors associated with PC use amongst patients who died of pancreatic cancer.

Methods: Deceased patients treated for pancreatic adenocarcinoma were identified using the 2004-2016 National Cancer Database. Multivariable logistic regression was used to evaluate patient, disease, and institutional features associated with PC use. Patients were classified into three categories based on survival: <6 months, 6-12 months, and 12+ months.

Results: A total of 296,617 patients were identified, of which 14.7% received PC. Patient characteristics with the largest percentages included: white (83.8%), Charlson-Deyo score of 0 (65.1%), Medicare (59.3%), metropolitan location with population >1 million (50.5%), stage IV cancer (45.2%), East Coast (43.3%), and treatment in an academic/research program (40.9%). Patients with stage II, III, and IV cancer had increased odds of receiving PC in all survival groups compared to stages 0 and I. The percentage of patients receiving PC was significantly greater in those surviving 12 months (17.0% vs. 9.7%, respectively). Multivariable logistic regression revealed that patients who received PC were more likely to be younger, Asian, Medicaid, recently diagnosed, have stage IIIV disease, not have a high school diploma, have a higher Charlson-Deyo score, report a median annual income <$38,000, and live in urban or rural areas.

Conclusions: Amongst patients diagnosed with pancreatic cancer, there is a national underutilization of PC with <15% of patients engaging in these services. Disparities are known to exist in both access to and provision of PC services. Identifying patterns associated with PC use is the first step towards closing this gap in health equity, as these factors can be used to create interventions aimed at increasing patient participation in these adjuncts.

Avertissement: Ce résumé a été traduit à l'aide d'outils d'intelligence artificielle et n'a pas encore été examiné ni vérifié.